NCT00093275 - HP184 in Chronic Spinal Cord Injury Subjects | Biotech Hunter

Enrollment

262

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions

Spinal Cord Injury

Interventions

DRUG

HP184

Trial Locations (5)

Sanofi-Aventis Administrative Office, Bridgewater

sanofi-aventis administrative Australia & New-Zealand administrative office, Macquarie Park, New South Wales

Sanofi-Aventis Administrative Office, Berlin

Sanofi-Aventis Administrative Office, Mumbai

Sanofi-Aventis Administrative Office, Guildford Surrey